ストックスクリーナーアプリを入手
0.532
6.10%
0.0306
アフターアワーズ：
.54
0.008
+1.50%
前日終値:
$0.5014
開ける：
$0.5237
24時間の取引高:
1.29M
Relative Volume:
0.75
時価総額：
$20.87M
収益：
$3.04M
当期純損益:
$-33.97M
株価収益率:
-0.40
EPS:
-1.33
ネットキャッシュフロー:
$-52.47M
1週間 パフォーマンス:
+28.01%
1か月 パフォーマンス:
+5.14%
6か月 パフォーマンス:
-64.53%
1年 パフォーマンス:
-81.46%
1日の値動き範囲:
$0.49
$0.54
1週間の範囲:
$0.401
$0.54
52週間の値動き範囲:
$0.387
$3.75
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
名前
Rani Therapeutics Holdings Inc
セクター
電話
(408) 457-3700
住所
2051 RINGWOOD AVENUE, SAN JOSE
RANI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
0.532 | 21.86M | 3.04M | -33.97M | -52.47M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-02 | 開始されました | Oppenheimer | Outperform |
| 2024-06-14 | 開始されました | Maxim Group | Buy |
| 2024-06-13 | 開始されました | Rodman & Renshaw | Buy |
| 2023-04-17 | 再開されました | BTIG Research | Buy |
| 2022-10-11 | 開始されました | UBS | Buy |
| 2022-07-27 | 開始されました | H.C. Wainwright | Buy |
| 2022-06-13 | 開始されました | Wedbush | Outperform |
すべてを表示
Rani Therapeutics Holdings Inc (RANI) 最新ニュース
How volatile is Rani Therapeutics Holdings Inc. stock compared to the marketLightning-fast capital gains - jammulinksnews.com
How many analysts rate Rani Therapeutics Holdings Inc. as a “Buy”Capitalize on emerging market sectors - jammulinksnews.com
What is the dividend policy of Rani Therapeutics Holdings Inc. stockGet real-time alerts on top stocks - jammulinksnews.com
When is Rani Therapeutics Holdings Inc. stock expected to show significant growthBuild a diversified portfolio for steady profits - jammulinksnews.com
Is it the right time to buy Rani Therapeutics Holdings Inc. stockSuperior stock growth - jammulinksnews.com
Does Rani Therapeutics Holdings Inc. stock perform well during market downturnsAchieve explosive financial results today - jammulinksnews.com
How Rani Therapeutics Holdings Inc. stock performs during market volatilitySmart Trading With Safety Margin - Newser
What makes Rani Therapeutics Holdings Inc. stock price move sharplyCapital Doubling Tips - Newser
Will Rani Therapeutics Holdings Inc. Stock Benefit from AI and Green Energy Trends3x Growth Potential - Newser
What analysts say about Rani Therapeutics Holdings Inc. stockExplosive returns - PrintWeekIndia
Is Rani Therapeutics Holdings Inc. a good long term investmentFree Wealth Planning Blueprint - Autocar Professional
Rani Therapeutics Holdings Inc. Stock Analysis and ForecastFree Trend-Following Techniques - Autocar Professional
What drives Rani Therapeutics Holdings Inc. stock priceBreakthrough investment results - jammulinksnews.com
Why Rani Therapeutics Holdings Inc. stock attracts strong analyst attentionDaily Swing Candidates - Newser
Rani Therapeutics Announces New Securities Purchase Agreement - The Globe and Mail
Rani Therapeutics Shares Drop Sharply Following $3 Million Direct Offering Announcement - MSN
Rani Therapeutics Shares Surge After ENDO 2025 Presentation Announcement - MSN
Rani Therapeutics stock plunges after $3 million registered direct offering By Investing.com - Investing.com India
Rani Therapeutics stock plunges after $3 million registered direct offering - Investing.com
Rani Therapeutics secures $3 million through registered direct offering By Investing.com - Investing.com South Africa
Rani Therapeutics secures $3 million through registered direct offering - Investing.com
Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering - The Manila Times
Rani Therapeutics Secures $3M Financing Deal: Biotech Firm Prices Shares at $0.40 in Strategic Offering - Stock Titan
Pre-market Movers: KAPA, CYCC, SONN, RANI... - RTTNews
Rani Therapeutics Holdings Inc (RANI) 財務データ
収益
当期純利益
現金流量
EPS
0.97%
0.22%
大文字化:
|
ボリューム (24 時間):